Press Release Archive

07.19.2007

Pfizer Receives Positive Opinion from CHMP for Celsentri(R) (maraviroc) for Treatment-Experienced Patients Infected with CCR5-Tropic HIV-1

07.18.2007

Pfizer Announces First Occupant in its Science Incubator

07.17.2007

Pfizer Reports Second-Quarter 2007 Results, Reconfirms Full-Year 2007 and 2008 Financial Guidance and Updates Progress on Immediate Business Priorities

07.09.2007

High Court in Dublin Rules in Pfizer's Favor in Patent Case, Lipitor Protected from Generic Competition until 2011

07.08.2007

Pfizer Recommends Rejection of Mini-Tender Offer by TRC Capital Corporation

06.29.2007

Crystal Trial Confirms Central Role of Irinotecan in Metastatic Colorectal Cancer

06.27.2007

Pfizer Declares a 29-cent Third-Quarter, 2007, Dividend

06.27.2007

Pfizer Board of Directors to Initiate Face-to-Face Meetings with Company's Institutional Investors on Corporate Governance Policies and Practices

06.27.2007

Pfizer Initiates Phase III Trial to Study Sunitinib Malate in Patients with Metastatic Colorectal Cancer

06.24.2007

Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke

06.22.2007

Exubera Demonstrated Pulmonary Safety with Blood Sugar Control in Three-Year Interim Analyses

06.21.2007

Pfizer's Lyrica Receives FDA Approval for Fibromyalgia Based on Expedited Review